What this study looked at
The mucopolysaccharidoses (MPS) are a group of inherited metabolic disorders that usually follow an aggressive and often fatal course, and they almost always affect the structures of the head and neck. This study reviewed the records of 23 MPS patients at an academic centre, together with a survey of their caregivers, to see how often ear, nose and throat (ENT) symptoms appeared before diagnosis and how often otolaryngologists recognised the underlying disease.
Key takeaways
- Before their MPS diagnosis, 20 of the 23 patients (87%) had experienced at least one ENT problem such as ear pain, an airway disorder, disturbed sleep, speech delay or suspected hearing loss.
- Ten of the 23 patients (43%) were seen by an otolaryngologist before diagnosis, yet the disease was not suspected during any of those visits.
- The findings suggest that greater awareness of MPS among otolaryngologists could lead to earlier diagnosis and better management.
Why it matters
Because ENT complaints so often come first, otolaryngologists are well placed to spot MPS sooner — and earlier recognition means treatment can begin when it can do the most good.
